Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in EBS — Emergent BioSolutions Inc.

CIK 902219 Boston, MA
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,273,473
+$18,132 QoQ
Shares Held
151,966
+0.5% QoQ
Ownership
0.296%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 194 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 69% None 31%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. EBS ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in EBS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,273,473 151,966
2026-03-31 $1,255,341 151,246
2025-12-31 $2,084,426 168,643
2025-09-30 $1,623,805 184,105
2025-06-30 $1,104,823 173,170
2025-03-31 $694,814 142,966
2024-12-31 $1,293,869 135,342
2024-09-30 $1,138,012 136,289
2024-06-30 $777,439 113,994
2021-03-31 $4,609,356 49,611
2020-12-31 $939,724 10,488
2020-09-30 $37,010,531 358,178
2020-06-30 $20,174,651 255,117
2020-03-31 $351,383 6,073